SCHEMBL9730289

SCHEMBL9730289

CC(=O)CC(=O)OC(=O)c1ccccc1C(=O)OCC(C)C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.71
TSHR P16473 5/20 0.71
MAPT P10636 2/20 0.47
TP53 P04637 2/20 0.47
MEN1 O00255 1/20 0.47
NPY1R P25929 1/20 0.47
NPY2R P49146 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
NPC1 O15118 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
CYP3A4 P08684 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2500704 0.86 TSHR (0.48) ALDH1A1TSHRTP53KMT2AATM
SCHEMBL8144263 0.84 ALDH1A1 (1.00) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL42787 0.84 ALDH1A1 (1.00) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL29387332 0.84 ALDH1A1 (1.00) ALDH1A1TSHRMAPTTP53MEN1
Acetic Acid SCHEMBL28172110 0.82 ALDH1A1 (0.89) ALDH1A1TSHRMAPTTP53MEN1
Ammonia Solution, Strong SCHEMBL28046886 0.82 ALDH1A1 (0.96) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL27345462 0.82 ALDH1A1 (0.96) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL27494884 0.82 ALDH1A1 (0.96) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL22164153 0.81 ALDH1A1 (0.86) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL5166633 0.81 ALDH1A1 (0.86) ALDH1A1TSHRMAPTTP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5149688-A Administering effective amounts of methotrexate and succinylacetone, a seven carbon ketoacid; for rheumatoid arthritis; autoimmune diseases CETUS CORPORATION (US) 1992-09-22 US disclosed
WO-1991016046-A1 USE OF ACETOACETYL CARBOXYLIC ACID DERIVATIVES FOR IMMUNOSUPPRESSION CETUS CORPORATION (US) 1991-10-31 WO disclosed